Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Autosomal dominante generalisierte Schilddrüsenhormonresistenz

Das Nichtansprechen auf Schilddrüsenhormon ist eine Erkrankung die auf Mutationen des Schilddrüsenhormonrezeptors beruht. Dies kann die beta- (THRB) oder alpha-Untereinheit (THRA) betreffen. Die Vererbung ist in beiden Fällen autosomal dominant. Bei den Patienten findet sich deutliche erhöhte Schilddrüsenhormonspiegel trotz einer euthyreoten Stoffwechsellage. Auch das TSH ist meist erhöht und befördert das Strumawachstum. Die Patienten fallen meist dadurch auf, dass sie extrem hohe Dosen an Schilddrüsenhormon zur Eindämmung des Strumawachstums benötigen.

Gliederung

Schilddrüsenhormonresistenz
Allan-Herndon-Dudley-Syndrom
Autosomal dominante generalisierte Schilddrüsenhormonresistenz
THRA
THRB
Autosomal rezessive generalisierte Schilddrüsenhormonresistenz
Gestörter Schilddrüsenhormon-Stoffwechsel
RXRA
Selektive hypophysäre Schilddrüsenhormonresistenz

Referenzen:

1.

Moran C et al. (2015) Resistance to thyroid hormone due to defective thyroid receptor alpha.

external link
2.

Weiss RE et al. (1996) Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor.

external link
3.

Hauser P et al. (1993) Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone.

external link
4.

Refetoff S et al. (1993) The syndromes of resistance to thyroid hormone.

external link
5.

Maxon HR et al. (1980) Euthyroid, familial hyperthyroxinemia.

external link
6.

Brooks MH et al. (1981) Familial thyroid hormone resistance.

external link
7.

Bantle JP et al. (1982) Resistance to thyroid hormones. A disorder frequently confused with Graves' disease.

external link
8.

Elewaut A et al. (1976) Familial partial target organ resistance to thyroid hormones.

external link
9.

Hopwood NJ et al. (1986) Familial partial peripheral and pituitary resistance to thyroid hormone: a frequently missed diagnosis?

external link
10.

Gharib H et al. (1985) Familial euthyroid hyperthyroxinemia secondary to pituitary and peripheral resistance to thyroid hormones.

external link
11.

Usala SJ et al. (1988) Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene.

external link
12.

Pohlenz J et al. (1999) Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.

external link
13.

Magner JA et al. (1986) Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei.

external link
14.

Sakurai A et al. (1989) Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta.

external link
15.

Usala SJ et al. (1990) A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

external link
16.

Usala SJ et al. (1991) A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.

external link
17.

Mamanasiri S et al. (2006) Mosaicism of a thyroid hormone receptor-beta gene mutation in resistance to thyroid hormone.

external link
18.

Tang Y et al. (2016) Resistance to thyroid hormone α, revelation of basic study to clinical consequences.

external link
19.

Vlaeminck-Guillem V et al. (2015) TRα receptor mutations extend the spectrum of syndromes of reduced sensitivity to thyroid hormone.

external link
20.

van Gucht ALM et al. (2017) Resistance to Thyroid Hormone due to Heterozygous Mutations in Thyroid Hormone Receptor Alpha.

external link
21.

OMIM.ORG article

Omim 188570 external link
22.

Orphanet article

Orphanet ID 97927 external link
Update: 14. August 2020
Copyright © 2005-2024 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz | Impressum